Search Results for: TLE5

Novel Interactant Symbol Name
Associated Pathways
Binding Drugs
Associated Diseases
MSX2 msh homeobox 2
  • Regulation of RUNX2 expression and activity
  • Enlarged parietal foramina/cranium bifidum
  • Craniosynostosis, including: Pfeiffer syndrome; Apert syndrome; Crouzon syndrome; Jackson-Weiss syndrome; Beare-Stevenson syndrome; Muenke craniosynostosis; Saethre-Chotzen syndrome; Craniosynostosis Boston type; Antley-Bixler syndrome; Carpenter syndrome; Craniofrontonasal dysplasia; Noonan syndrome; Baller-Gerold syndrome
MTUS2 microtubule associated scaffold protein 2
MVP major vault protein
  • Neutrophil degranulation
MYF5 myogenic factor 5
  • Myogenesis
  • Myogenesis
MYH7B myosin heavy chain 7B
MYO15B myosin XVB
MYOG myogenin
  • Myogenesis
  • Myogenesis
NAB2 NGFI-A binding protein 2
  • NGF-stimulated transcription
  • NGF-stimulated transcription
  • EGR2 and SOX10-mediated initiation of Schwann cell myelination
NAF1 nuclear assembly factor 1 ribonucleoprotein
NBPF19 NBPF member 19
NCDN neurochondrin
NDOR1 NADPH dependent diflavin oxidoreductase 1
  • Cytosolic iron-sulfur cluster assembly
NDUFB7 NADH:ubiquinone oxidoreductase subunit B7
  • Respiratory electron transport
  • Complex I biogenesis
  • NADH
NEK6 NIMA related kinase 6
  • Activation of NIMA Kinases NEK9, NEK6, NEK7
  • Nuclear Pore Complex (NPC) Disassembly
  • EML4 and NUDC in mitotic spindle formation
NOTCH2NLA notch 2 N-terminal like A
NTAQ1 N-terminal glutamine amidase 1
NUDT22 nudix hydrolase 22
NUTF2 nuclear transport factor 2
NUTM1 NUT midline carcinoma family member 1
OLIG3 oligodendrocyte transcription factor 3

Page 11 out of 19 pages